Back to search

Article

Children’s Oncology Group’s 2023 Blueprint for Research: Cellular Therapy and Stem Cell Transplantation

2023-07-06

Abstract excerpt

Since the publication of the last Cellular Therapy and Stem Cell Transplant blueprint in 2013, Children’s Oncology Group cellular therapy-based trials for advanced the field and created new standards of care across a wide spectrum of pediatric cancer diagnoses. Key findings include that tandem autologous transplant improved survival for patients with neuroblastoma and atypical teratoid/rhabdoid brain tumors, one u...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ffcad2b-5f37-5197-88de-a8b092fc8356
DOI
10.22541/au.168864332.23180439/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Children’s Oncology Group’s 2023 Blueprint for Research: Cellular Therapy and Stem Cell TransplantationDOI 10.22541/au.168864332.23180439/v1
Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasms.Semantic proximity
Leukemia stem cells in 2010: Current understanding and future directionsSemantic proximity
Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapiesSemantic proximity
Future Directions in Allogeneic Stem Cell Transplantation in Acute Lymphoblastic LeukemiaSemantic proximity
Identifying leukemia stem cells – Is it feasible and does it matter?Semantic proximity
60 Years Young: The Evolving Role of Allogeneic Hematopoietic Stem Cell Transplantation in Cancer ImmunotherapySemantic proximity
Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trialSemantic proximity
The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies.Semantic proximity
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantationSemantic proximity
Allogeneic Hematopoietic Stem Cell Transplantation in Infant Leukemia: Vague Prospects? (Series Cases and Brief Review)Semantic proximity
Efficacy and Safety of Matched Unrelated Donor Hematopoietic Stem Cell Transplantation for Non–Down syndrome Acute Megakaryoblastic Leukemia: A Long-Term Follow-Up StudySemantic proximity
Post-stem cell transplant maintenance for pediatric acute leukemias: insights from a Brazilian institution with a Latin American perspectiveSemantic proximity
Select a neighboring publication to make it the new centre.